Compare KALV & BV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KALV | BV |
|---|---|---|
| Founded | N/A | 1939 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2014 | 2018 |
| Metric | KALV | BV |
|---|---|---|
| Price | $26.79 | $12.47 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | ★ $32.60 | $14.50 |
| AVG Volume (30 Days) | ★ 5.4M | 601.1K |
| Earning Date | 07-09-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $50,000,000.00 | N/A |
| Revenue This Year | $185.42 | $4.61 |
| Revenue Next Year | $59.23 | $1.90 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 495.66 | N/A |
| 52 Week Low | $9.83 | $11.06 |
| 52 Week High | $26.85 | $17.11 |
| Indicator | KALV | BV |
|---|---|---|
| Relative Strength Index (RSI) | 74.93 | 50.76 |
| Support Level | $14.25 | $11.34 |
| Resistance Level | $26.85 | $13.29 |
| Average True Range (ATR) | 0.07 | 0.47 |
| MACD | -0.19 | -0.03 |
| Stochastic Oscillator | 75.00 | 39.61 |
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.